AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INVION LTD

0.080

-0.003-3.61%

Volume:1.00

Turnover:0.08

Market Cap:6.20M

PE:-0.76

High:0.080

Open:0.080

Low:0.080

Close:0.083

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVION LTD

Exchange:

ASX

Establishment Date:

2000

Employees:

4

Office Location:

100 Albert Road,Level 4,Melbourne,Victoria,Australia

Website:

http://www.inviongroup.com

Zip Code:

3205

Phone:

Fax:

- -

Introduction:

Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.08,"timestamp":1747980720000,"preClose":0.083,"halted":0,"volume":1,"delay":0,"nameEN":"INVION LTD","floatShares":48948056,"shares":77478388,"eps":-0.105328,"marketStatus":"Market Closed","change":-0.003,"latestTime":"05-23 16:12:00 AEST","open":0.08,"high":0.08,"low":0.08,"amount":0.08,"amplitude":0,"askPrice":0.088,"askSize":18000,"bidPrice":0.08,"bidSize":28714,"shortable":3,"etf":0,"ttmEps":-0.105328,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1748217600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1747958400000,1747980000000]],"volumeRatio":0.000012655344377545056,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":48948056,"roa":"-26.39%","roe":"-43.80%","lyrEps":-0.087599,"volumeRatio":0.000012655344377545056,"shares":77478388,"dividePrice":0,"high":0.08,"amplitude":0,"preClose":0.083,"low":0.08,"week52Low":0.079,"pbRate":"0.47","psRate":"4.23","week52High":0.5,"institutionHeld":0,"latestPrice":0.08,"committee":0.229353,"eps":-0.105328,"divideRate":0,"volume":1,"delay":0,"ttmEps":-0.105328,"open":0.08,"prevYearClose":0.28,"prevWeekClose":0.095,"prevMonthClose":0.1,"prevQuarterClose":0.1,"fiveDayClose":0.095,"twentyDayClose":0.1,"sixtyDayClose":0.14},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":28625535,"yearFounded":2000,"employeeNum":4,"address":"100 Albert Road,Level 4,Melbourne,Victoria,Australia","zipCode":"3205","officePhone":"61 3 9692 7222"},"stockCompanyDetail":{"websiteUrl":"http://www.inviongroup.com","stockEarnings":[{"period":"1week","weight":-0.1579},{"period":"1month","weight":-0.2},{"period":"3month","weight":-0.3043},{"period":"6month","weight":-0.6},{"period":"1year","weight":-0.84},{"period":"ytd","weight":-0.7143}],"compareEarnings":[{"period":"1week","weight":0.0226},{"period":"1month","weight":0.0516},{"period":"3month","weight":0.09},{"period":"6month","weight":0.1813},{"period":"1year","weight":0.1798},{"period":"ytd","weight":0.1434}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.035796},{"month":2,"riseRate":0.4375,"avgChangeRate":0.115888},{"month":3,"riseRate":0.25,"avgChangeRate":0.010159},{"month":4,"riseRate":0.1875,"avgChangeRate":-0.038136},{"month":5,"riseRate":0.2,"avgChangeRate":-0.105251},{"month":6,"riseRate":0.6,"avgChangeRate":0.138105},{"month":7,"riseRate":0.2,"avgChangeRate":-0.065701},{"month":8,"riseRate":0.266667,"avgChangeRate":0.064653},{"month":9,"riseRate":0.333333,"avgChangeRate":0.012276},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.034855},{"month":11,"riseRate":0.266667,"avgChangeRate":-0.067962},{"month":12,"riseRate":0.4,"avgChangeRate":0.128117}],"exchange":"ASX","name":"INVION LTD","nameEN":"INVION LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[]}}